同种异体造血干细胞移植患者结膜印象细胞学的研究及其与眼移植物抗宿主病的关系

Thanuja Gopal Pradeep, Deepthi Rameshbabu Honniganur, Santhosh Kumar Devadas
{"title":"同种异体造血干细胞移植患者结膜印象细胞学的研究及其与眼移植物抗宿主病的关系","authors":"Thanuja Gopal Pradeep, Deepthi Rameshbabu Honniganur, Santhosh Kumar Devadas","doi":"10.22336/rjo.2025.12","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To assess the proportion of patients with dry eye syndrome and to examine the changes in conjunctival impression cytology (CIC) in all patients undergoing hematopoietic stem cell transplantation (HSCT) by employing CIC as a diagnostic tool for ocular graft vs. host disease (oGVHD).</p><p><strong>Materials and methods: </strong>Every patient who received HSCT underwent a thorough ophthalmic examination, which included visual acuity, an assessment of dry eyes using objective tests such as Schirmer's I test, tear film break-up time, and subjective tests such as the Ocular Surface Disease Index (OSDI) questionnaire. Conjunctival impression cytology was conducted after that, following informed consent.</p><p><strong>Results: </strong>This study included 24 eyes from 12 patients who underwent allogeneic hematopoietic stem cell transplantation (HSCT), with a mean age of 31.4 ± 11.06 years. Dry eye disease was observed in 28.8% of the cases. Based on the symptoms, 16 eyes (66.67%) were diagnosed with oGVHD. The Ocular Surface Disease Index (OSDI) indicated mild symptoms in 4 eyes (16.67%), moderate symptoms in 11 eyes (45.33%), and severe symptoms in 1 eye (4.17%) in individuals with ocular GVHD. In contrast, 93.55% of eyes without oGVHD exhibited mild symptoms, while 6.71% showed moderate symptoms (p = 0.002).Objective assessments indicated that Schirmer's I score was ≤ 5 mm in 50% of the eyes (n = 12), and tear film breakup time was less than 5 seconds (3.85 ± 2.18 seconds) in 29.17% of eyes with oGVHD (p = 0.05). The conjunctival impression cytology (CIC) was abnormal in 9 eyes (37.5%, p = 0.05), revealing changes in cell morphology, such as decreased goblet cell density, reduced cytoplasmic mucin, and inflammatory cells. The average goblet cell density was measured at 190.63 ± 81.00 cells/mm<sup>2</sup> in 6 eyes (p = 0.05), showing a correlation with the time since HSCT; specifically, when the interval from HSCT to CIC assessment was 40.67 ± 5.01 months, the goblet cell density significantly decreased to 181.00 ± 76.62 (p = 0.04).Changes in morphology were observed in 8 eyes with oGVHD (91.7%) compared to 2 eyes without oGVHD (16.67%), with abnormal CIC results in 66.67% of cases (p = 0.02).</p><p><strong>Discussion: </strong>This study highlights the significant prevalence of dry eye disease (DED) and ocular surface alterations in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), particularly in those diagnosed with ocular graft-versus-host disease (oGVHD). The findings align with previous research, indicating that oGVHD is a leading cause of post-HSCT ocular morbidity, with symptoms ranging from mild irritation to severe ocular surface damage. The significantly higher Ocular Surface Disease Index (OSDI) scores, reduced Schirmer's I test values, and shorter tear film breakup times (TBUT) in oGVHD patients corroborate established diagnostic criteria for severe tear dysfunction. Moreover, conjunctival impression cytology (CIC) revealed marked goblet cell loss and squamous metaplasia, consistent with prior studies linking these changes to chronic inflammation and epithelial instability in oGVHD. The correlation between longer post-HSCT duration and further reduction in goblet cell density underscores the progressive nature of ocular surface damage in these patients. Given its non-invasive nature and diagnostic accuracy, CIC is a valuable tool for early oGVHD detection, facilitating timely therapeutic intervention and potentially mitigating long-term ocular complications.</p><p><strong>Conclusion: </strong>Significant alterations in the ocular surface were noted in those who had chronic oGVHD and had undergone allo-HSCT. The Ocular Surface Disease Index (OSDI) score, corneal involvement severity, and Schirmer I test results are key indicators of ocular involvement following allogeneic hematopoietic stem cell transplantation (allo-HSCT). The most notable abnormalities observed in the conjunctival impression cytology of eyes with oGVHD include squamous cell metaplasia and reduced goblet cell density, with lesser changes noted in eyes without oGVHD. Therefore, conjunctival impression cytology is advisable for patients who have received allogeneic HSCT to facilitate the early diagnosis of oGVHD.</p>","PeriodicalId":94355,"journal":{"name":"Romanian journal of ophthalmology","volume":"69 1","pages":"68-73"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12049656/pdf/","citationCount":"0","resultStr":"{\"title\":\"A study of conjunctival impression cytology in patients undergoing allogeneic hematopoietic stem cell transplantation and its relationship with Ocular Graft versus Host Disease.\",\"authors\":\"Thanuja Gopal Pradeep, Deepthi Rameshbabu Honniganur, Santhosh Kumar Devadas\",\"doi\":\"10.22336/rjo.2025.12\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To assess the proportion of patients with dry eye syndrome and to examine the changes in conjunctival impression cytology (CIC) in all patients undergoing hematopoietic stem cell transplantation (HSCT) by employing CIC as a diagnostic tool for ocular graft vs. host disease (oGVHD).</p><p><strong>Materials and methods: </strong>Every patient who received HSCT underwent a thorough ophthalmic examination, which included visual acuity, an assessment of dry eyes using objective tests such as Schirmer's I test, tear film break-up time, and subjective tests such as the Ocular Surface Disease Index (OSDI) questionnaire. Conjunctival impression cytology was conducted after that, following informed consent.</p><p><strong>Results: </strong>This study included 24 eyes from 12 patients who underwent allogeneic hematopoietic stem cell transplantation (HSCT), with a mean age of 31.4 ± 11.06 years. Dry eye disease was observed in 28.8% of the cases. Based on the symptoms, 16 eyes (66.67%) were diagnosed with oGVHD. The Ocular Surface Disease Index (OSDI) indicated mild symptoms in 4 eyes (16.67%), moderate symptoms in 11 eyes (45.33%), and severe symptoms in 1 eye (4.17%) in individuals with ocular GVHD. In contrast, 93.55% of eyes without oGVHD exhibited mild symptoms, while 6.71% showed moderate symptoms (p = 0.002).Objective assessments indicated that Schirmer's I score was ≤ 5 mm in 50% of the eyes (n = 12), and tear film breakup time was less than 5 seconds (3.85 ± 2.18 seconds) in 29.17% of eyes with oGVHD (p = 0.05). The conjunctival impression cytology (CIC) was abnormal in 9 eyes (37.5%, p = 0.05), revealing changes in cell morphology, such as decreased goblet cell density, reduced cytoplasmic mucin, and inflammatory cells. The average goblet cell density was measured at 190.63 ± 81.00 cells/mm<sup>2</sup> in 6 eyes (p = 0.05), showing a correlation with the time since HSCT; specifically, when the interval from HSCT to CIC assessment was 40.67 ± 5.01 months, the goblet cell density significantly decreased to 181.00 ± 76.62 (p = 0.04).Changes in morphology were observed in 8 eyes with oGVHD (91.7%) compared to 2 eyes without oGVHD (16.67%), with abnormal CIC results in 66.67% of cases (p = 0.02).</p><p><strong>Discussion: </strong>This study highlights the significant prevalence of dry eye disease (DED) and ocular surface alterations in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), particularly in those diagnosed with ocular graft-versus-host disease (oGVHD). The findings align with previous research, indicating that oGVHD is a leading cause of post-HSCT ocular morbidity, with symptoms ranging from mild irritation to severe ocular surface damage. The significantly higher Ocular Surface Disease Index (OSDI) scores, reduced Schirmer's I test values, and shorter tear film breakup times (TBUT) in oGVHD patients corroborate established diagnostic criteria for severe tear dysfunction. Moreover, conjunctival impression cytology (CIC) revealed marked goblet cell loss and squamous metaplasia, consistent with prior studies linking these changes to chronic inflammation and epithelial instability in oGVHD. The correlation between longer post-HSCT duration and further reduction in goblet cell density underscores the progressive nature of ocular surface damage in these patients. Given its non-invasive nature and diagnostic accuracy, CIC is a valuable tool for early oGVHD detection, facilitating timely therapeutic intervention and potentially mitigating long-term ocular complications.</p><p><strong>Conclusion: </strong>Significant alterations in the ocular surface were noted in those who had chronic oGVHD and had undergone allo-HSCT. The Ocular Surface Disease Index (OSDI) score, corneal involvement severity, and Schirmer I test results are key indicators of ocular involvement following allogeneic hematopoietic stem cell transplantation (allo-HSCT). The most notable abnormalities observed in the conjunctival impression cytology of eyes with oGVHD include squamous cell metaplasia and reduced goblet cell density, with lesser changes noted in eyes without oGVHD. Therefore, conjunctival impression cytology is advisable for patients who have received allogeneic HSCT to facilitate the early diagnosis of oGVHD.</p>\",\"PeriodicalId\":94355,\"journal\":{\"name\":\"Romanian journal of ophthalmology\",\"volume\":\"69 1\",\"pages\":\"68-73\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12049656/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Romanian journal of ophthalmology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22336/rjo.2025.12\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Romanian journal of ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22336/rjo.2025.12","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:通过将结膜印象细胞学(CIC)作为眼移植物抗宿主病(oGVHD)的诊断工具,评估干眼综合征患者的比例,并检查所有接受造血干细胞移植(HSCT)患者结膜印象细胞学(CIC)的变化。材料和方法:每位接受HSCT的患者都进行了全面的眼科检查,包括视力,使用Schirmer's I试验等客观测试评估干眼,泪膜破裂时间,以及眼表疾病指数(OSDI)问卷等主观测试。在知情同意后,进行结膜印象细胞学检查。结果:本研究纳入了12例接受同种异体造血干细胞移植(HSCT)患者的24只眼,平均年龄31.4±11.06岁。干眼病占28.8%。根据症状,16只眼(66.67%)被诊断为oGVHD。眼表疾病指数(OSDI)显示GVHD患者轻度症状4只眼(16.67%),中度症状11只眼(45.33%),重度症状1只眼(4.17%)。无oGVHD的93.55%为轻度症状,6.71%为中度症状(p = 0.002)。客观评价显示50%的眼(n = 12)的Schirmer's I评分≤5 mm, 29.17%的眼(p = 0.05)泪膜破裂时间小于5秒(3.85±2.18秒)。结膜印象细胞学(CIC)异常9眼(37.5%,p = 0.05),表现为细胞形态改变,如杯状细胞密度降低,细胞质粘蛋白减少,炎症细胞增多。6只眼的杯状细胞平均密度为190.63±81.00个细胞/mm2 (p = 0.05),与HSCT后时间相关;当HSCT与CIC间隔40.67±5.01个月时,杯状细胞密度显著降低至181.00±76.62 (p = 0.04)。oGVHD患者形态学改变8例(91.7%),未oGVHD患者2例(16.67%),CIC异常占66.67% (p = 0.02)。讨论:本研究强调了在接受同种异体造血干细胞移植(alloo - hsct)的患者中干眼病(DED)和眼表改变的显著患病率,特别是在那些被诊断为眼部移植物抗宿主病(oGVHD)的患者中。这些发现与先前的研究一致,表明oGVHD是hsct后眼部发病的主要原因,其症状从轻度刺激到严重的眼表损伤不等。oGVHD患者显著较高的眼表疾病指数(OSDI)评分、较低的Schirmer's I试验值和较短的泪膜破裂时间(TBUT)证实了严重泪液功能障碍的既定诊断标准。此外,结膜印象细胞学(CIC)显示明显的杯状细胞丢失和鳞状化生,这与先前的研究一致,这些变化与oGVHD的慢性炎症和上皮不稳定有关。hsct后持续时间较长与杯状细胞密度进一步降低之间的相关性强调了这些患者眼表损伤的进行性。由于CIC的非侵入性和诊断准确性,它是早期检测oGVHD的宝贵工具,有助于及时的治疗干预,并有可能减轻长期眼部并发症。结论:慢性oGVHD患者行同种异体造血干细胞移植后,眼表有明显改变。眼表疾病指数(OSDI)评分、角膜受累程度和Schirmer I试验结果是同种异体造血干细胞移植(alloo - hsct)后眼部受累的关键指标。在患有oGVHD的眼睛结膜印象细胞学中观察到的最显著异常包括鳞状细胞化生和杯状细胞密度降低,而在没有oGVHD的眼睛中观察到的变化较小。因此,对于接受同种异体造血干细胞移植的患者,结膜印象细胞学检查是可取的,以促进oGVHD的早期诊断。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A study of conjunctival impression cytology in patients undergoing allogeneic hematopoietic stem cell transplantation and its relationship with Ocular Graft versus Host Disease.

Purpose: To assess the proportion of patients with dry eye syndrome and to examine the changes in conjunctival impression cytology (CIC) in all patients undergoing hematopoietic stem cell transplantation (HSCT) by employing CIC as a diagnostic tool for ocular graft vs. host disease (oGVHD).

Materials and methods: Every patient who received HSCT underwent a thorough ophthalmic examination, which included visual acuity, an assessment of dry eyes using objective tests such as Schirmer's I test, tear film break-up time, and subjective tests such as the Ocular Surface Disease Index (OSDI) questionnaire. Conjunctival impression cytology was conducted after that, following informed consent.

Results: This study included 24 eyes from 12 patients who underwent allogeneic hematopoietic stem cell transplantation (HSCT), with a mean age of 31.4 ± 11.06 years. Dry eye disease was observed in 28.8% of the cases. Based on the symptoms, 16 eyes (66.67%) were diagnosed with oGVHD. The Ocular Surface Disease Index (OSDI) indicated mild symptoms in 4 eyes (16.67%), moderate symptoms in 11 eyes (45.33%), and severe symptoms in 1 eye (4.17%) in individuals with ocular GVHD. In contrast, 93.55% of eyes without oGVHD exhibited mild symptoms, while 6.71% showed moderate symptoms (p = 0.002).Objective assessments indicated that Schirmer's I score was ≤ 5 mm in 50% of the eyes (n = 12), and tear film breakup time was less than 5 seconds (3.85 ± 2.18 seconds) in 29.17% of eyes with oGVHD (p = 0.05). The conjunctival impression cytology (CIC) was abnormal in 9 eyes (37.5%, p = 0.05), revealing changes in cell morphology, such as decreased goblet cell density, reduced cytoplasmic mucin, and inflammatory cells. The average goblet cell density was measured at 190.63 ± 81.00 cells/mm2 in 6 eyes (p = 0.05), showing a correlation with the time since HSCT; specifically, when the interval from HSCT to CIC assessment was 40.67 ± 5.01 months, the goblet cell density significantly decreased to 181.00 ± 76.62 (p = 0.04).Changes in morphology were observed in 8 eyes with oGVHD (91.7%) compared to 2 eyes without oGVHD (16.67%), with abnormal CIC results in 66.67% of cases (p = 0.02).

Discussion: This study highlights the significant prevalence of dry eye disease (DED) and ocular surface alterations in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), particularly in those diagnosed with ocular graft-versus-host disease (oGVHD). The findings align with previous research, indicating that oGVHD is a leading cause of post-HSCT ocular morbidity, with symptoms ranging from mild irritation to severe ocular surface damage. The significantly higher Ocular Surface Disease Index (OSDI) scores, reduced Schirmer's I test values, and shorter tear film breakup times (TBUT) in oGVHD patients corroborate established diagnostic criteria for severe tear dysfunction. Moreover, conjunctival impression cytology (CIC) revealed marked goblet cell loss and squamous metaplasia, consistent with prior studies linking these changes to chronic inflammation and epithelial instability in oGVHD. The correlation between longer post-HSCT duration and further reduction in goblet cell density underscores the progressive nature of ocular surface damage in these patients. Given its non-invasive nature and diagnostic accuracy, CIC is a valuable tool for early oGVHD detection, facilitating timely therapeutic intervention and potentially mitigating long-term ocular complications.

Conclusion: Significant alterations in the ocular surface were noted in those who had chronic oGVHD and had undergone allo-HSCT. The Ocular Surface Disease Index (OSDI) score, corneal involvement severity, and Schirmer I test results are key indicators of ocular involvement following allogeneic hematopoietic stem cell transplantation (allo-HSCT). The most notable abnormalities observed in the conjunctival impression cytology of eyes with oGVHD include squamous cell metaplasia and reduced goblet cell density, with lesser changes noted in eyes without oGVHD. Therefore, conjunctival impression cytology is advisable for patients who have received allogeneic HSCT to facilitate the early diagnosis of oGVHD.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信